NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 11.80% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.77% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 6.54% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 5.96% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.73% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.62% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.56% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.98% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.92% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.79% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.55% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 3.24% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.22% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 3.15% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.04% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.60% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 2.27% |